Colorectal cancer and dostarlimab – An episode in discovery to new era of immunotherapy-Reference-Cited by-同舟云学术

Colorectal cancer and dostarlimab – An episode in discovery to new era of immunotherapy

Published:2023 Issue:5 Volume:19 Page:1490-1491
ISSN:0973-1482
Container-title:Journal of Cancer Research and Therapeutics
language:en
Short-container-title:

Author:

Bethineedi Lakshmi Deepak¹,Kutikuppala L. V. Simhachalam²,Boppana Sri Harsha³,Kuchana Sai Kiran⁴,Ponnaganti Sai Venkata Kalyani⁵

Affiliation:

1. Department of General Surgery, Andhra Medical College, Visakhapatnam, Andhra Pradesh, India

2. Department of General Surgery, Dr. NTR University of Health Sciences, Vijayawada, Andhra Pradesh, India

3. Department of Anaesthesiology, Division of Perioperative Informatics, University of California, San Diego, La Jolla, CA, USA

4. Department of General Surgery, Kakatiya Medical College, Warangal, Telangana, India

5. Department of General Surgery, Rangaraya Medical College, Kakinada, Andhra Pradesh, India

Publisher

Medknow

Subject

Radiology, Nuclear Medicine and imaging,Oncology,General Medicine

Reference5 articles.

1. Global colorectal cancer burden in 2020 and projections to 2040;Xi;Transl Oncol,2021

2. Immune checkpoint blockade therapy in patients with colorectal cancer harboring microsatellite instability/mismatch repair deficiency in 2022;Andre;Am Soc Clin Oncol Educ Book,2022

3. IOLite:Phase 1b trial of doublet/triplet combinations of dostarlimab with niraparib, carboplatin-paclitaxel, with or without bevacizumab in patients with advanced cancer;Yap;J Immunother Cancer,2022

4. PD-1 blockade in mismatch repair-deficient, locally advanced rectal cancer;Cercek;N Engl J Med,2022

5. Blockade of novel immune checkpoints and new therapeutic combinations to boost antitumor immunity;Archilla-Ortega;J Exp Clin Cancer Res,2022

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Activation of M2 macrophage autophagy by rapamycin increases the radiosensitivity of colorectal cancer xenografts;Journal of Cancer Research and Therapeutics;2024-04